On February 13, 2020, the manufacturer of the prescription weight loss drug Belviq® and Belviq XR® (“Belviq”) pulled the drugs from the market after being urged to do so by the FDA.
These drugs are sometimes called lorcaserin.
The FDA’s withdrawal request advised patients to immediately stop taking the drug and dispose of the pills.
In 2015 alone, over 600,000 prescriptions were filled for the drug.
The drug has been on the market since 2012.
According to a recent study, a 5-year trial found people taking Belviq were more likely to develop certain types of cancer including: